Activation of the Nrf2-ARE pathway attenuates hyperglycemia-mediated injuries in mouse podocytes

Cellular Physiology and Biochemistry

Volumn 34, Issue 3, 2014, Pages 891-902

  Wang, Cheng ^a   Li, Cui Cui ^a,b   Peng, Hui ^a   Ye, Zengchun ^a   Zhang, Jun ^a   Liu, Xun ^a   Lou, Tanqi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidant response element; High glucose; Nuclear factor (erythroid derived 2) like 2; Podocyte; Tert Butylhydroquinone

Indexed keywords

BOVINE SERUM ALBUMIN; CATALASE; GLUCOSE; GLUTATHIONE; HYDROGEN PEROXIDE; MALONALDEHYDE; SMALL INTERFERING RNA; SUPEROXIDE; SUPEROXIDE DISMUTASE; SYNAPTOPODIN; TERT BUTYLHYDROQUINONE; TRANSCRIPTION FACTOR NRF2; 2-TERT-BUTYLHYDROQUINONE; HYDROQUINONE DERIVATIVE; NFE2L2 PROTEIN, MOUSE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL DAMAGE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HYPERGLYCEMIA; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE;

BOVINAE;

ANIMALS; BASE SEQUENCE; GENE EXPRESSION REGULATION; GLUCOSE; HYDROQUINONES; HYPERGLYCEMIA; MICE; NF-E2-RELATED FACTOR 2; PODOCYTES; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING;

EID: 84910113245     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000366307     Document Type: Article

References (25)

1. Giacco F, Brownlee M: Oxidative stress and diabetic complications. Cirs Res 2010;107:1058-1070.
2. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-1625.
3. West IC: Radicals and oxidative stress in diabetes. Diabet Med 2000;17:171-180.
4. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide productionblocks three pathways ofhyperglycaemic damage. Nature 2000;404:787-790.
5. Jim B, Ghanta M, Qipo A, Fan Y, Chuang PY, Cohen HW, Abadi M, Thomas DB, He JC: Dysregulated nephrin in diabetic nephropathy oftype 2 diabetes: a cross sectional study. PLoS One Doi: 10.1371/journal. pone.0036041.
6. Shankland SJ, Pippin JW, Reiser J, Mündel P: Podocytes in culture: past, present, and future. Kidney Int 2007;72:26-36.
7. Hoshi S, Shu Y, Yoshida F, Inagaki T, Sonoda J, Watanabe T, Nomoto K, Nagata M: Podocyte injury promotes progressive nephropathy in zuckerdiabeticfattyrats. Lab Invest2002;82:25-35.
8. Coimbra TM, Janssen U, Grone HJ, Ostendorf T, Runter U, Schmidt H, Brabant G, Floege J: Early events leading to renal injury in obese Zucker rats with type II diabetes. Kidney Int 2000;57:167-182.
9. Menini S, Iacobini C, Oddi G, Ricci C, Simonelli P, Fallucca S, Grattarola M, Pugliese F, Pesce C, Pugliese G: Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role inthe development of diabetic glomerular disease. Diabetologia 2007;50:2591-2599.
10. Biswal S, Thimmulappa RK, Harvet CJ: Experimental therapeutias of nrf2 as a target for prevention of bacterial exacerbations in COPD. Proc Am Thorac Soc 2012;9:47-51.
11. Jaiswal AK: Regulation of genes of encoding NADPH:quinine oxidoreductases. Free Radic Biol Med 2000;29:254-262.
12. Harvey CJ, Thimmulappa RK, Singh A, Blake DJ, Ling G, Wakabayashi N, Fujii J, Myers A, Biswal S: Nrf2 regulated glutathione recucling independent of biosyntheisi is critical for cell survival during oxidative stress. Free Radic Biol Med 2009;46:443-453.
13. Zhong Q, Mishra M, Kowluru RA: Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci 2013;54:3941-3941.
14. Tsai CY, Wang CC, Lai TY, Tsu HN, Wang CH, Liang HY, Kuo WW: Antioxidant effect of diallyl trisulfide on high glucose-indueed apoptosis are mediated by the PI3K-Akt-dependentactivation ofNrf2 in cardiomyocytes. Int J Cardiol 2013;30:1286-1297.
15. LiH, Wang F, Zhang L, Cao Y, Liu W Hao J, Liu Q, Duan H: Modulation of Nrf2 expression alters high glucose-induced oxidative stress and antioxidant gene expression in mouse mesangial cells. Cell Signal 2011;23:1625-1632.
16. Ungvari Z, Bailey-Downs L, Gautam T, Jimenez R, Losonczy G, Zhang C, Ballabh P, Recchia FA, Wilkerson DC, SonntagWE, Pearson K, de Cabo R, CsiszarA: Adaptive induction ofNF-E2-related factor-2 driven antioxidant genes in endothelial cells in respone to hyperglycemia. Am J Physiol Heart Circ Physiol 2011;300:H1133-1140.
17. Wang C, Liu X, Tang Y, Peng H, Ye Z, Zhang J, Tang H, Lou T: Medium from meangial cells incubated with aggregated IgAl from IgA nephropathy patients reduces podocyte adhesion through activation of the rennin angiotensin system. Swiss Med Wkly Doi: 10.4414/smw.2011.13304 .
18. Wang C, Liu X, Ke Z, Tang Y, Li CC, Li CM, Ye Z, Zhang J, Lou T: Mesangial medium form IgA nephropathy patients induces podocyte epithelial to mesenchymal transition through activation of the phosphatidyl inositol-3-kinase/Aktsignalingpathway. Cell Physiol Biochem 2012;29:743-752.
19. Jirapan Moungjaroen, Ubonthip Nimmannit, Patrick S: Callery:Reactive Oxygen Species Mediate Caspase Activation and Apoptosis Induced by Lipoic Acid in Human Lung Epithelial Cancer Cells through Bcl-2 Down-Regulation. J Pharmacol Exp Ther 2006;319:1062-1069.
20. Kumar S, Allen DA, Kieswich JE, Patel NS, Harwood S, Mazzon E, Cuzzocrea S, Raftery MJ, Thiemermann C, Yaqoob MM: Dexamethasone Ameliorates Renal Ischemia-Reperfusion Injury. J Am Soc Nephrol 2009;20:2412-2425.
21. Forbes JM, Coughlan MT, Cooper ME: Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008;57:1446-1454.
22. Samuni Y, Goldstein S, Dean OM, Berk M: The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta. 2013;1830:4117-4129.
23. Jiang T, Huang Z, Lin Y, Zhang Z, Fang D, Zhang DD:The protective role of nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes 2010;59:850-860.
24. Zheng H, Whitman SA, Wu W, Wondrak GT, Wong PK, Fang D, Zhang DD: Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes 2011;60:3055-3066.
25. Piantadosi CA, Carraway MS, Babiker A, Suliman HB: Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via nrf2-mediated transcriptional control of nuclear respiratory factor. Cir Res 2008;103:1232-1240.